Effects of TNF-α inhibitors upon the mechanisms of action of VEGF

Anti-TNF-α Inhibitors: A New Therapeutic Approach for Inflammatory Immune-Mediated Diseases: An Update upon Efficacy and Adverse Events

(2017) G. Murdaca et al.   INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY

Effect of biologic therapies targeting tumour necrosis factor-α on cutaneous mesenchymal stem cells in psoriasis

(2012) A. Campanati et al.   BRITISH JOURNAL OF DERMATOLOGY

Adalimumab specifically induces CD3+ CD4+ CD25high Foxp3+ CD127− T-regulatory cells and decreases vascular endothelial growth factor plasma levels in refractory immuno-mediated uveitis: a non-randomized pilot intervention study

(2012) S Calleja et al.   EYE

Determination of Lymphotoxin-Alpha Levels in Patients with Psoriatic Arthritis Undergoing Etanercept Treatment

(2012) Giuseppe Murdaca et al.   JOURNAL OF INTERFERON AND CYTOKINE RESEARCH

Infliximab Therapy Inhibits Inflammation-Induced Angiogenesis in the Mucosa of Patients With Crohn's Disease

(2011) Sergio Rutella et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Emerging biological drugs: A new therapeutic approach for Systemic Lupus Erythematosus. An update upon efficacy and adverse events

(2011) Giuseppe Murdaca et al.   AUTOIMMUNITY REVIEWS

Update upon efficacy and safety of TNF-α inhibitors

(2011) Giuseppe Murdaca et al.   Expert Opinion On Drug Safety

Anti-Tumor Necrosis Factor-α Treatment with Infliximab for Disseminated Granuloma Annulare

(2010) Giuseppe Murdaca et al.   AMERICAN JOURNAL OF CLINICAL DERMATOLOGY

The role of endothelial cell apoptosis in the effect of etanercept in psoriasis

(2010) G. Avramidis et al.   BRITISH JOURNAL OF DERMATOLOGY

Effect of etanercept on serum levels of soluble cell adhesion molecules (sICAM-1, sVCAM-1, and sE-selectin) and vascular endothelial growth factor in patients with rheumatoid arthritis

(2009) PA Klimiuk et al.   SCANDINAVIAN JOURNAL OF RHEUMATOLOGY

Serum vascular endothelial growth factor and sublingual immunotherapy

(2008) G. Ciprandi et al.   ALLERGY

Effects of infliximab on markers of inflammation and bone turnover and associations with bone mineral density in patients with ankylosing spondylitis

(2008) S Visvanathan et al.   ANNALS OF THE RHEUMATIC DISEASES

Histological analysis of synovium in cases of effect attenuation associated with infliximab therapy in rheumatoid arthritis

(2008) Katsuaki Kanbe et al.   CLINICAL RHEUMATOLOGY

Serum vascular endothelial growth factor in allergic rhinitis and systemic lupus erythematosus

(2008) Giorgio Ciprandi et al.   HUMAN IMMUNOLOGY

Serum levels of biomarkers of bone and cartilage destruction and new bone formation in different cohorts of patients with axial spondyloarthritis with and without tumor necrosis factor-alpha blocker treatment

(2008) Heiner Appel et al.   ARTHRITIS RESEARCH & THERAPY